Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Encephalitis | Case report

Ad26.COV2-S/tozinameran

Acute disseminated encephalomyelitis and acute encephalitis

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Weidauer S, et al. Acute Disseminated Encephalomyelitis and Acute Encephalitis Following Vaccination Against SARS-CoV-2: Two Case Reports and Review of Literature. [Review] Fortschritte der Neurologie Psychiatrie 91 : 319-325, Jan 2023. Available from: URL: 10.1055/a-2029-4405 Weidauer S, et al. Acute Disseminated Encephalomyelitis and Acute Encephalitis Following Vaccination Against SARS-CoV-2: Two Case Reports and Review of Literature. [Review] Fortschritte der Neurologie Psychiatrie 91 : 319-325, Jan 2023. Available from: URL: 10.1055/a-2029-4405
Metadata
Title
Ad26.COV2-S/tozinameran
Acute disseminated encephalomyelitis and acute encephalitis
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54706-0

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Morphine

Case report

Phenobarbital

Case report

Lamotrigine

Case report

Bleomycin